Infectious Disease CRO
Infectious Disease CRO: Expertise, Services, and Capabilities for Clinical Trials Infectious diseases remain one of the most challenging areas in clinical development. Driven by rapidly evolving pathogens, emerging outbreaks, rising antimicrobial resistance, and the global burden of viral and bacterial infections, drug and vaccine developers increasingly rely on specialized Clinical Research Organizations (CROs) to accelerate clinical trials, ensure compliance, and deliver high-quality data. This article Read more
Clinical Research Focus. 47th Edition Clinical Research Focus featuring topical articles of interest to the clinical trial community. Explore the news of December 2025. Read more
Cancer Vaccines 2025, Part II: The Rise of DNA Cancer Vaccines | Cromos Pharma
Cancer Vaccines 2025, Part II: The Rise of DNA Cancer Vaccines Cancer vaccines are entering a new era — and it’s no longer just about mRNA. A powerful second wave is gaining momentum: DNA cancer vaccines. Read more
cancer vaccines
Cancer Vaccines 2025, Part I: The mRNA Revolution The race to develop cancer vaccines is accelerating. Fueled by decades of research, mRNA platforms have emerged as a leading modality in oncology, delivering early clinical signals across multiple tumor types. This article kicks off our multi-part series on the evolving landscape of cancer vaccines. We begin with therapeutic mRNA vaccines, the most clinically advanced Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us